Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
BUSINESS OF BIOTECHNOLOGY
They're perfecting scientific developments that could cure the world's toughest diseases, improve food production, and even yield energy alternatives. This is the exciting world of biotechnology, where young companies fight to make innovative discoveries -- and to find new and innovative ways of funding those innovations.
Business of Biotechnology is part of Business Exchange, suggested by
Arlene Weintraub.
This topic contains
1,249 news
and
4,710 blog
items.
Read updated news, blogs, and resources about Business of Biotechnology. Find user-submitted articles and reactions on Business of Biotechnology from
like-minded professionals.
Blogs
Recent blog posts on this topic.
Two biotech players offered price ranges for their hoped-for initial public offerings, Renaissance Capital reported.
Clavis Pharmaceuticals shares flat-lined at about 18 cents this morning as the Norwegian biotech company outlined a...
Botox had better watch out. Another next-gen cosmetic therapy gunning to offer a simpler replacement for the temporary...
An early snapshot of preliminary data from a midstage study of an experimental lung cancer drug at a Karolinska...
Today's Telegraph gives AstraZeneca ($AZN) a rousing hurrah today in a lengthy piece, noting that its plans to build a...
The small, struggling PolyMedix ($PYMX) has thrown in the towel and handed over the company to a bankruptcy court.
Copyright © thinkBiotech Journal of Commercial Biotechnology Vol 19, Issue 2 (2013) Capturing Value G.
After a pair of trial setbacks with a separate program from ArQule, Japan-based drugmaker Daiichi Sankyo has decided to...
The analysts at Thomson Reuters have been crunching the numbers and found that the life sciences industry produced the...
Months after the beleaguered BioCryst Pharmaceuticals ($BCRX) started reading the last rites for its long-running Phase...
Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.
Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.
Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.
Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.
Copyright © thinkBiotech Cancer is one of the most challenging diseases of all - not only in terms of the clinical...
Copyright © thinkBiotech The development and commercialization of new therapeutics have had immense impact on the...
Copyright © thinkBiotech On December 7, 2011, Secretary of Health and Human Services Kathleen Sebelius overruled a...
Copyright © thinkBiotech The technology of monoclonal antibodies has been developed since the 1990s and is attracting...
Copyright © thinkBiotech Social media is becoming increasingly important in business. While the lack of regulations...
Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.
Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.
Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.
Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.
Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.
Top Sources: Business of Biotechnology
- Biotech Blog
- News
- Health Beat
- frontendofinnovation.blogspot.com
- Nature Biotechnology
- The Biotech Weblog
- policyinnovations.org
- Science Progress
- LinkedIn Answers: Technology
- World Pharma News / Published News
account